Pi-Cardia
Formerly Pi R Squared
Non-implant-based Valve Treatment
Startup C Health Tech & Life Sciences Est. 2009
Total Raised
$37M
C
Last Round
Undisclosed
5 rounds
Investors
9
9 public
Team
2
51-200 employees
Confidence
90/100
News
11
articles
Patents
1
About
Pi-Cardia is a medical device company developing a low-profile catheter for treating aortic stenosis. The company's proprietary technology is based on delivering mechanical impact to create fractures in valve calcifications without injuring the surrounding soft tissue. This treatment, which takes only seconds, is intended to increase the valve's effective orifice area, eliminating the need to replace the valve.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
medical-devicescardiovascularsurgerycardiologycathetersvalvessurgeonsmedical-productstreatments
Funding & Events
Sep 2015
B Round Undisclosed
Accelmed, Clal Biotechnology Industries (CBI)
Nov 2024
Undisclosed Round Undisclosed
Minogue Consulting (Lead)
Jan 2016
C Round $10M
Innogest Capital, Clal Biotechnology Industries (CBI), Atlante Ventures, Viventures, Anatomy Medical Technology Fund
Dec 2011
A Round Undisclosed
Apr 2020
C Round $27M
Sofinnova Partners (Lead), Jacques Sguin , Clal Biotechnology Industries (CBI)
News (11)
Aug 22, 2022 · www.biospace.com
growth-positive
Pi-Cardia Successfully Performs Mitral Valve Splitting With ShortCut(TM) | BioSpace
CustomersExpand
Jul 26, 2022 · www.accesswire.com
growth-positive
Pi-Cardia Receives FDA IDE Approval for Pivotal Study with ShortCut(TM) Device
CustomersExpand
Feb 27, 2022 · www.israel21c.org
growth-positive
Innovative non-surgical solutions for aortic valve stenosis
Customers
Jan 1, 2021 · www.businesswire.com
Pi-Cardia Successfully Treats First Patients with ShortCut™ Device
Jul 14, 2020 · en.globes.co.il
growth-positive
Heart valve co Pi-Cardia teams with China's Venus Medtech
Partners
Apr 20, 2020 · www.prnewswire.com
growth-positive
Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex™ Aortic Valve Technology
Investment
Oct 16, 2019 · cardiology2.com
Pi-Cardia Appoints Prof. Jacques Séguin As Chairman " Cardiology2.0
May 22, 2019 · www.prnewswire.com
growth-positive
Pi-Cardia First-in-Human Study Shows Significant Improvement in Aortic Valve Function Following Treatment With its Novel Non-Implant Based Leaflex™ Catheter
CustomersPartners
May 16, 2018 · www.prnewswire.com
growth-positive
Pi-Cardia Initiates First-in-Human Study With Novel Non-Implant Based Treatment of Aortic Stenosis
Expand
Jan 7, 2016 · www.prnewswire.com
growth-positive
Pi-Cardia Completes $10M Financing
Investment
May 12, 2011 · www.globes.co.il
growth-positive
Clal Biotech to invest in heart valve co Pi R Squared
Investment
Details
Product Stage
Clinical Trial
Employees
51-200
Exact Count
68
District
Center District
Founded
2009
Registrar
514181379
Crunchbase
pi-cardia
Locations
David Fikes St 5, Rehovot, Israel
Links
Website
LinkedIn
Twitter
Admin
Last Update
Dec 23, 2024
Verified by
Yanina Wainscheinker
Missing
markets, not claimed
Team (2)
Erez Golan
Co-founder & CEO
Founder
Eyal Kolka
Co-founder & Director
Founder
Internal
Created by
Raz Zohar (raz@platterz.ca)
Created
2014-09-10T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)